Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sertraline for Premenstrual Dysphoric Disorder
NCT00536198Phase 4Completed
- Sponsor
- Yale University
- Start
- Nov 2007
- Primary completion
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sertraline in Premenstrual Dysphoric Disorder (PMDD), sponsored by Yale University. Started Nov 2007; status: completed.
02
Drugs
sertraline
03
Conditions
Premenstrual Dysphoric Disorder (PMDD)
Beyond the preview
Go deeper on NCT00536198.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00536198.